Factors Associated With the Use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) mHealth App in Routine Follow-Up After Gynecologic Cancer Treatment: Observational Study
JMIR Cancer · 2026-07-31 · 12 · e89918-e89918
DOI: 10.2196/89918 ↗At a glance
Beobachtungsstudie in JMIR Cancer, published online on 2026-07-31. Written by Zaklina Tarabar and 5 co-authors. Institution: Hospital of Southern Norway, Egsveien 100, Kristiansand, Agder, 4615, Norway, 47 91840889. Major MEDLINE topics: Mobile Applications, Genital Neoplasms, Female, Cancer Survivors, Life Style. 57 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
Mobile health (mHealth) apps offer new opportunities to support cancer survivors in managing their health, adopting healthier lifestyles, and increasing awareness of recurrence symptoms. However, despite their potential, little is known about survivors’ use of such tools in routine follow-up care, or which factors are associated with their engagement.
Objective
The aim of the present study was to identify survivor characteristics associated with the use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) app. In addition, we aimed to describe engagement patterns among gynecologic cancer survivors during the first year of follow-up after treatment.
Methods
App data from 378 participants in the intervention group of the LETSGO multicenter clinical trial were included in the analysis. Using multiple logistic regression, we analyzed app data from the first year of LETSGO app use to identify participant characteristics associated with use. In addition, we described the frequency of user interactions with app features and identified the most frequently used features during the first year of the intervention in a subset of 49 participants with complete app log data.
Results
Of the 378 participants in the intervention group, 267 (70.6%) used the LETSGO app at least twice and were defined as app users. The median age of app users was 63 (53-70) years vs 70 (60-78) years among app nonusers ( P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Hospital of Southern Norway, Egsveien 100, Kristiansand, Agder, 4615, Norway, 47 91840889.
- Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
- Department of Digital Health Research, Division of Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Nursing and Health Sciences, Faculty of Health and Social Sciences, University of South-Eastern Norway, Drammen, Norway.
- Department of Sport Science and Physical Education, University of Agder, Kristiansand, Agder, Norway.
- Research Unit, Sorlandet Hospital, Kristiansand, Norway.
ORCID profiles: Zaklina Tarabar, Elin Børøsund, Sindre H Fosstveit, Sveinung Berntsen, Milada Hagen, Ingvild Vistad
Cite
APA
Tarabar, Z., Børøsund, E., H Fosstveit, S., Berntsen, S., Hagen, M., & Vistad, I. (2026). Factors Associated With the Use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) mHealth App in Routine Follow-Up After Gynecologic Cancer Treatment: Observational Study. JMIR Cancer, 12, e89918-e89918. https://doi.org/10.2196/89918
Vancouver
Tarabar Z, Børøsund E, H Fosstveit S, Berntsen S, Hagen M, Vistad I. Factors Associated With the Use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) mHealth App in Routine Follow-Up After Gynecologic Cancer Treatment: Observational Study. JMIR Cancer. 2026;12:e89918-e89918. doi:10.2196/89918
BibTeX
@article{Tarabar2026,
author = {Tarabar, Zaklina and Børøsund, Elin and H Fosstveit, Sindre and Berntsen, Sveinung and Hagen, Milada and Vistad, Ingvild},
title = {Factors Associated With the Use of the Lifestyle and Empowerment Techniques in Survivorship of Gynecologic Oncology (LETSGO) mHealth App in Routine Follow-Up After Gynecologic Cancer Treatment: Observational Study},
journal = {JMIR Cancer},
year = {2026},
volume = {12},
pages = {e89918--e89918},
doi = {10.2196/89918}
}
EUVIMED